comprehensive -WSS

comprehensive

author：hotspot 2025-08-04 12:36:40 - browse：47531

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

leisure time

WSS

What we owe ALS patients — and why one company fell short

Nobel honors Karikó and Weissman's enduring partnership

With Roe v Wade overturned, abortion providers work to adapt

Lawsuit highlights wrinkle for disputes over surprise medical bills

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Oak Street deal isn't the answer to health care's woes

explore

comprehensive

Wikipedia

Wildfire smoke exposes gaps in outdoor worker protections

Nobel honors Karikó and Weissman's enduring partnership

Guidelines to prevent youth baseball injuries need more muscle

The United States must get value

In Memoriam: Notable people who died in 2023

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

New air purifier tech could be key to improving indoor air quality

Free medical tuition alone isn't enough to close gaps in primary care

Hepatitis C has a cure — but many Americans still lack access to it

Nobel honors Karikó and Weissman's enduring partnership

knowledge

ALS treatment from Biogen, Ionis fails in study

Boston hospital trains restaurant workers on naloxone for overdoses

The biotech scorecard for Q4: 16 stock

HHS suspends federal funding for EcoHealth Alliance

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Free medical tuition alone isn't enough to close gaps in primary care

entertainment

leisure time

focus

Wikipedia